Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SURGERY PARTNERS, INC.

(SGRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

SURGERY PARTNERS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

08/17/2021 | 06:57am EDT

Item 7.01 Regulation FD Disclosure.

Over the course of the next several weeks, Surgery Partners, Inc. (the "Company") management intends to meet with investors and analysts to provide an update on the strategy and execution of the Company. During these meetings, management may discuss information contained in the Company's updated Investor Presentation, dated August 2021, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K. Beginning on August 17, 2021, a copy of the Investor Presentation can also be found in the Investors section of the Company's website at www.surgerypartners.com.

The information in this Current Report and in the accompanying exhibit is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities under that Section and shall not be deemed to be incorporated by reference into any filing of the Registrant under the Securities Act of 1933, as amended, or the Exchange Act.

Item 9.01 Financial Statements and Exhibits.





(d) Exhibits.



Exhibit No.   Description
  99.1          Investor Presentation, dated August 2021
104           Cover Page Interactive Data File (embedded within the Inline XBRL document)

© Edgar Online, source Glimpses

All news about SURGERY PARTNERS, INC.
10/18SURGERY PARTNERS : Shares Rise After SVB Leerink Initiates Coverage at Outperform
MT
10/18SURGERY PARTNERS : SVB Leerink Starts Surgery Partners at Outperform with $50 Price Target
MT
10/14SURGERY PARTNERS : Inc. Announces Third Quarter 2021 Earnings Release Date and Conference ..
GL
09/10SURGERY PARTNERS : Cowen Starts Surgery Partners at Market Perform with $50 Price Target
MT
08/17SURGERY PARTNERS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form..
AQ
08/16SURGERY PARTNERS : Investor Presentation - August 2021 (PDF)
PU
08/04SURGERY PARTNERS : Management's Discussion and Analysis of Financial Condition and Results..
AQ
08/04Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on December 15..
CI
08/04SURGERY PARTNERS : Posts Narrower Q2 Loss on Higher Revenue; Reiterates FY21 Guidance
MT
08/04SURGERY PARTNERS : Q2 Earnings Snapshot
AQ
More news
Analyst Recommendations on SURGERY PARTNERS, INC.
More recommendations
Financials (USD)
Sales 2021 2 217 M - -
Net income 2021 -23,1 M - -
Net Debt 2021 2 496 M - -
P/E ratio 2021 -44,8x
Yield 2021 -
Capitalization 3 325 M 3 325 M -
EV / Sales 2021 2,63x
EV / Sales 2022 2,41x
Nbr of Employees 9 950
Free-Float 38,7%
Chart SURGERY PARTNERS, INC.
Duration : Period :
Surgery Partners, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SURGERY PARTNERS, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 41,03 $
Average target price 63,13 $
Spread / Average Target 53,9%
EPS Revisions
Managers and Directors
J. Eric Evans Chief Executive Officer & Director
Thomas F. Cowhey CFO, Principal Accounting Officer & Executive VP
Wayne S. DeVeydt Executive Chairman
Varun Gadhok Chief Information Officer & Senior Vice President
Roxanne Womack Chief Compliance Officer & Senior Vice President